Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545310 · ClinicalTrials.gov registry record · Phase 1

A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia

A Phase 1 study of Schizophrenia, sponsored by Abbott.

Completed
Registry status
Phase 1
Development phase
18
Enrollment target
1
Study location

NCT01545310 is a Phase 1 study of Schizophrenia that has completed, run by Abbott. The registered enrollment target is 18 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545310, a Phase 1 study of Schizophrenia, has completed, sponsored by Abbott.

COMPLETED
Registry status
Phase 1
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

This open-label, Phase 1 study will investigate the 5-hydroxytryptamine 6 (5-HT6) receptor occupancy in the brain using positron emission tomography (PET) following single oral doses of SLV354. Up to 22 healthy male subjects and male subjects with stable schizophrenia, between 18-55 years of age are to complete the study.

Conditions Studied

Schizophrenia

Interventions

  • DRUG SLV354

Study Locations (1)

Connecticut

  • Site Reference ID/Investigator# 52162 - New Haven

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2011-05
Est. Completion 2012-07
Phase Phase 1

Sponsor

Abbott

181 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01545310

The ClinicalTrials.gov registry entry for NCT01545310 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (92% lower). The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which SLV354 is the first listed.

NCT01545310 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01545310 about?

NCT01545310 is a clinical study titled "A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia". This open-label, Phase 1 study will investigate the 5-hydroxytryptamine 6 (5-HT6) receptor occupancy in the brain using positron emission tomography (PET) following single oral doses of SLV354. Up to 22 healthy male subjects and male subjects with stable schizophrenia, between 18-55 years of age are...

What is the current status of trial NCT01545310?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2011-05. Estimated completion is 2012-07.

What conditions does trial NCT01545310 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT01545310?

The interventions under investigation include: SLV354 (DRUG).

Who is sponsoring clinical trial NCT01545310?

This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01545310 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.